| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.8613 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.7693 | 58 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.6205 | 30 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.9368 | 22 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.1376 | 52 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.2734 | 55 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 54.0184 | 58 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 55.0725 | 60 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.2696 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 52.2398 | 55 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.4836 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 57.1418 | 62 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.8422 | 56 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.5195 | 47 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.8401 | 31 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.4782 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 60.662 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.6062 | 25 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 68.9135 | 69 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 58.8026 | 64 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 54.0362 | 58 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.4587 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 62.2996 | 66 |